13045_2019_834_MOESM1_ESM.docx (20.79 kB)

MOESM1 of First-in-human phase I study of BPI-9016M, a dual MET/Axl inhibitor, in patients with non-small cell lung cancer

Download (20.79 kB)
journal contribution
posted on 17.01.2020, 09:49 by Xingsheng Hu, Xin Zheng, Sheng Yang, Lin Wang, Xuezhi Hao, Xinge Cui, Lieming Ding, Li Mao, Pei Hu, Yuankai Shi
Additional file 1. Exclusion and inclusion criteria


China National Major Project for New Drug Innovation